Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06589310 · ClinicalTrials.gov registry record
Falcon Real World Evidence Registry
A clinical trial of Cancer, sponsored by Exact Sciences Corporation.
- Recruiting
- Registry status
- 25,000
- Enrollment target
- 2
- Study locations
NCT06589310: Recruiting study of Cancer, sponsored by Exact Sciences Corporation.
NCT06589310 is a study of Cancer that is actively recruiting participants, run by Exact Sciences Corporation. The registered enrollment target is 25,000 participants, above the 3,450-participant average among 615 other Cancer trials with a reported enrollment target (625% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06589310, a study of Cancer, is actively recruiting participants, sponsored by Exact Sciences Corporation.
- RECRUITING
- Registry status
- 25,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a multi-site registry of patients receiving the Exact Sciences Multicancer Early Detection (MCED) test.
Conditions Studied
Interventions
- DEVICE Exact Sciences Multicancer Early Detection (MCED) Test
Study Locations (2)
Illinois
- Endeavor Health - Evanston
Texas
- Baylor Scott & White Health - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25,000 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2031-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06589310
The ClinicalTrials.gov registry entry for NCT06589310 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,450-participant average among 615 other Cancer trials with a reported enrollment target (625% higher). The listed sponsor is Exact Sciences Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exact Sciences Multicancer Early Detection (MCED) Test is the first listed.
NCT06589310 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Texas.
Frequently Asked Questions
What is clinical trial NCT06589310 about?
NCT06589310 is a clinical study titled "Falcon Real World Evidence Registry". This is a multi-site registry of patients receiving the Exact Sciences Multicancer Early Detection (MCED) test.
What is the current status of trial NCT06589310?
This trial is currently recruiting. The enrollment target is 25,000 participants. The study started on 2024-08-01. Estimated completion is 2031-01.
What conditions does trial NCT06589310 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT06589310?
The interventions under investigation include: Exact Sciences Multicancer Early Detection (MCED) Test (DEVICE).
Who is sponsoring clinical trial NCT06589310?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06589310 being conducted?
This trial has 2 study locations across Illinois, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.